Ovarian Response and Pregnancy Outcome Related to Midfollicular LH Levels in Down-Regulated Women Undergoing Assisted Reproduction

Journal of Reproductive Medicine for the Obstetrician and Gynecologist

Volumn 49, Issue 3, 2004, Pages 148-152

  Ferrari, Bruno ^a   Barusi, Lorenzo ^a   Lanna, Mariano ^a   Coppola, Francesco ^a  

^a UNIVERSITY OF PARMA   (Italy)

Author keywords

Fertilization in vitro; Luteinizing hormone; Pregnancy outcome; Reproductive techniques

Indexed keywords

CHORIONIC GONADOTROPIN; ESTRADIOL; GONADORELIN DERIVATIVE; LEUPRORELIN; LUTEINIZING HORMONE; PROGESTERONE; RECOMBINANT FOLLITROPIN;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; EMBRYO TRANSFER; ESTRADIOL BLOOD LEVEL; FEMALE; FERTILIZATION IN VITRO; GENE EXPRESSION REGULATION; HUMAN; LUTEAL PHASE; LUTEINIZING HORMONE BLOOD LEVEL; MAJOR CLINICAL STUDY; OVARY FOLLICLE; OVARY FOLLICLE MATURATION; OVARY FUNCTION; OVARY HYPERSTIMULATION; PREGNANCY RATE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TECHNIQUE; TRANSVAGINAL ECHOGRAPHY;

ABSORBABLE IMPLANTS; ADULT; FEMALE; FERTILIZATION IN VITRO; FOLLICLE STIMULATING HORMONE; HUMANS; INJECTIONS, SUBCUTANEOUS; LEUPROLIDE; LUTEINIZING HORMONE; OVARY; OVULATION INDUCTION; PREGNANCY; PREGNANCY OUTCOME; PROSPECTIVE STUDIES;

EID: 1642464942     PISSN: 00247758     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Jacobs FS, Porter R, Eshel A, et al: Profertility uses of LHRH agonist analogues. In LHRH and Its Analogues: Contraception and Therapeutic Application. Edited by BH Vickey, IJ Nestor. Lancaster, Pennsylvania, MTP Press, 1987, pp 303-319
2. Humaidan P, Bungum L, Bungum M, et al: Ovarian response and pregnancy outcome related to mid-follicular LH levels in women undergoing assisted reproduction with GnRH agonist down-regulation and recombinant FSH stimulation. Hum Reprod 2002;17:2016-2021
3. Hillier SG: Gonadotrophic control of ovarian follicular growth and development. Mol Cell Endocrinol 2001;179:39-46
4. Ferrari B, Barusi L, Coppola F: Clinical and endocrine effects of ovulation induction with FSH and hCG supplementation in low responders in the midfollicular phase: A pilot study. J Reprod Med 2002;47:137-143
5. Balasch J, Vidal F, Penarrubia L, et al: Suppression of LH during ovarian stimulation: Analysing threshold values and effects on ovarian response and the outcome of assisted reproduction in down-regulated women stimulated with recombinant FSH. Hum Reprod 2001;16:1636-1643
6. Feldberg D, Farhi J, Ashkenazi J, et al: Minidose gonadotropin-releasing hormone agonist in the treatment of choice in poor responders with high follicle-stimulating hormone levels. Fertil Steril 1994;62:343-346
7. Ben-Rafael Z, Lipitz S, Bider D, et al: Ovarian hyporesponsiveness in combined gonadotropin-releasing hormone-agonist and menotropin therapy is associated with low serum follicle-stimulating hormone levels. Fertil Steril 1991;55:272-275
8. Sheehan KI, Casper RF, Yen SSC: Induction of luteolysis by luteinizing hormone releasing factor (LRF) agonist: Sensitivity, reproducibility and reversibility. Fertil Steril 1982;37:209-212
9. Westergaard LG, Erb K, Laursen SB, et al: Human menopausal gonadotrophin versus recombinant follicle-stimulating hormone in normogonadotropic women down-regulated with a gonadotrophin-releasing hormone agonist who were undergoing in vitro fertilization and intracytoplasmic sperm injection: A prospective randomized study. Fertil Steril 2001;76:543-549
10. Loumaye E, Engrand P, Howles CM, et al: Assessment of the role of serum luteinizing hormone and estradiol response to follicle stimulating hormone on in vitro fertilization treatment outcome. Fertil Steril 1997;67:889-899
11. Short RV: Steroids in the follicular fluid and the corpus luteum of the mare: A two cell type theory of ovarian steroid synthesis. J Endocrinol 1962;24:59-63
12. Filicori M: The role of luteinizing hormone in folliculogenesis and ovulation induction. Fertil Steril 1999;71:405-414
13. Westergaard LG, Erb K, Laursen S, et al: The effect of human menopausal gonadotrophin and highly purified, urine-derived follicle stimulating hormone on the outcome of in-vitro fertilization in down-regulated normogonadotrophic women. Hum Reprod 1996;11:1209-1213
14. Soderstrom-Anttila V, Foudila T, Hovatta O: A randomized comparative study of highly purified follicle stimulating hormone and human menopausal gonadotrophin for ovarian hyperstimulation in an oocyte donation programme. Hum Reprod 1996;11:1864-1870
15. Gordon UD, Harrison RF, Fawzy M, et al: A randomized prospective assessor-blind evaluation of luteinizing hormone dosage and in vitro fertilization outcome. Fertil Steril 2001;75:324-331
16. Schoolcraft W, Gardner DK, Lane M, et al: Blastocyst culture and transfer: Analysis of results and parameters affecting outcome in two in vitro fertilization programs. Fertil Steril 1999;72:604-609
17. Fleming R, Lloyd F, Herbert M, et al: Effects of profound suppression of luteinizing hormone during ovarian stimulation on follicular activity, oocyte and embryo function in cycles stimulated with purified follicle stimulating hormone. Hum Reprod 1998;13:1788-1792
18. The Ganirelix Dose-Finding Study Group: A double-blind, randomised, dose-finding study to assess the efficacy of the GnRH antagonist Ganirelix (Org 37462) to prevent premature LH surges in women undergoing controlled ovarian hyperstimulation with recombinant FSH (Puregon). Hum Reprod 1998;13:3023-3031
19. Westergaard LG, Erb K, Laursen S, et al: Human menopausal gonadotropin versus recombinant follicle-stimulating hormone in normogonadotropic women down-regulated with a gonadotropin-releasing hormone agonist who were undergoing in vitro fertilization and intracytoplasmic sperm injection: A perspective randomized study. Fertil Steril 2001;76:543-549
20. Westergaard LG, Lausen SB, Andersen CY: Increased risk of early pregnancy loss by profound suppression of LH during ovarian stimulation in normogonadotropic women undergoing assisted reproduction. Hum Reprod 2000;15:1003-1008
21. Yoshimura Y, Wallach EE: Studies of the mechanism(s) of mammalian ovulation. Fertil Steril 1987;47:22-34
22. Esposito M, Bamhart KT, Coutifaris C, et al: Role of periovulatory luteinizing hormone concentrations during assisted reproductive technology cycles stimulated exclusively with recombinant follicle-stimulating hormone. Fertil Steril 2001;75:519-523
23. Coppola F, Potì ER, Barusi L, et al: Profound luteinizing hormone suppression induces a deleterious follicular environment during assisted reproduction technology. Fertil Steril 2003;79:459-460